Vaccines, blood, antisera, toxins and cultures in   North Korea

Exports In 2023, North Korea exported $3.71M in Vaccines, blood, antisera, toxins and cultures, making it the 81st largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 16th most exported product in North Korea. The main destination of Vaccines, blood, antisera, toxins and cultures exports from North Korea are: Mozambique ($2.45M), Niger ($805k), Angola ($438k), Burkina Faso ($17.9k), and Spain ($1.65k).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of North Korea between 2022 and 2023 were Mozambique ($2.45M), Angola ($438k), and Burkina Faso ($17.9k).

Imports In 2023, North Korea imported $109k in Vaccines, blood, antisera, toxins and cultures, becoming the 208th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 382nd most imported product in North Korea. North Korea imports Vaccines, blood, antisera, toxins and cultures primarily from: United States ($61.3k), China ($42.3k), Netherlands ($5.53k), and Brunei ($1).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for North Korea between 2022 and 2023 were United States ($61.3k) and Brunei ($1).